CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction is a research paper published in Research Square (2023). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: 1R01DK131786-01A1
Role of SMPDL3B in obesity-associated non-alcoholic fatty liver disease
National Institutes of Health
Grant: 5P30GM127211-05
Center of Research on Obesity and Cardiovascular Disease
National Institutes of Health
Grant: 1R01DK098176-01A1
Thrombospondin 1 in obesity associated inflammation and insulin resistance
National Institutes of Health
Grant: 5I01BX004252-02
CD47 as a therapeutic target for obesity
Fields of Study
Keywords
Sustainable Development Goals